Our study, a placebo-controlled randomized trial, delves into the efficacy of specific dietary fiber supplements—glucomannan, inulin, and psyllium—in individuals with obesity-related genetic polymorphisms within genes such as FTO, LEP, LEPR, and MC4R. The gene discussed is FTO; the disease is obesity disorder.